Skip to main content

Sleeping Beauty

Fatal Forty DDI: fentanyl, ritonavir, CYP3A4

  • Chapter
A Case Approach to Perioperative Drug-Drug Interactions

Abstract

This case discusses the pharmacokinetic interaction between fentanyl and ritonavir, leading to prolonged narcotic action. Fentanyl is a cytochrome P450 3A4 substrate and ritonavir is a 3A4 inhibitor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Labroo RB, Paine MF, Thummel KE, et al. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab Dispos. 1997;25(9):1072–80.

    PubMed  CAS  Google Scholar 

  2. McClain DA, Hug Jr CC. Intravenous fentanyl kinetics. Clin Pharmacol Ther. 1980;28(1):106–14.

    Article  PubMed  CAS  Google Scholar 

  3. Olkkola KT, Palkama VJ, Neuvonen PJ. Ritonavir’s role in reducing fentanyl clearance and prolonging its half-life. Anesthesiology. 1999;91(3):681–5.

    Article  PubMed  CAS  Google Scholar 

  4. Kharasch ED, Whittington D, Hoffer C. Minimal influence of hepatic & intestinal CYP3A activity on the acute disposition & effect of oral transmucosal fentanyl (OTFC) [abstract]. Anesthesiology. 2003;99:A515.

    Article  Google Scholar 

  5. Rowland M, Tozer TN. Elimination. In: Clinical pharmacokinetics: concepts and applications. 3rd ed. Baltimore: Williams & Wilkins; 1995. p. 156–83.

    Google Scholar 

  6. Feierman DE, Lasker JM. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes: role of CYP3A4. Drug Metab Dispos. 1996;24(9):932–9.

    PubMed  CAS  Google Scholar 

  7. Kharasch ED, Bedynek PS, Walker A, et al. Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: II. Ritonavir effects of CYP3A and P-glycoprotein activities. Clin Pharmacol Ther. 2008;84(4):506–12.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Piscitelli SC, Kress DR, Bertz RJ, et al. The effect of ritonavir on the pharmacokinetics of meperidine and normeperidine. Pharmacotherapy. 2000;20(5):549–53.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hans P. Sviggum MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sviggum, H.P., Sprung, J. (2015). Sleeping Beauty. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_55

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7495-1_55

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7494-4

  • Online ISBN: 978-1-4614-7495-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics